User profiles for OSCAR ARRIETA
Oscar ArrietaHead of the Thoracic Oncology Unit, Instituto Nacional de Cancerología de Mexico Verified email at unam.mx Cited by 26808 |
[HTML][HTML] Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer
…, F Barlesi, M Kohlhäufl, O Arrieta… - … England Journal of …, 2015 - Mass Medical Soc
Background Nivolumab, a fully human IgG4 programmed death 1 (PD-1) immune-checkpoint–inhibitor
antibody, disrupts PD-1–mediated signaling and may restore antitumor immunity. …
antibody, disrupts PD-1–mediated signaling and may restore antitumor immunity. …
[HTML][HTML] Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with …
O Arrieta, RM Michel Ortega, G Villanueva-Rodríguez… - BMC cancer, 2010 - Springer
Background A frequent manifestation of advanced NSCLC is malnutrition, even though
there are many studies which relate it with a poor survival, its relation with toxicity has not yet …
there are many studies which relate it with a poor survival, its relation with toxicity has not yet …
Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer
Ó Arrieta, LP Angulo, C Núñez-Valencia… - Annals of surgical …, 2013 - Springer
Background Symptoms of depression and anxiety are common in patients with lung cancer
and may produce an impact on both health-related quality of life (HRQL) and survival. The …
and may produce an impact on both health-related quality of life (HRQL) and survival. The …
[HTML][HTML] The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis
Background Hepatocellular carcinoma is the most common cause of primary liver
neoplasms and is one of the main causes of death in patients with liver cirrhosis. High Alpha …
neoplasms and is one of the main causes of death in patients with liver cirrhosis. High Alpha …
Effect of metformin plus tyrosine kinase inhibitors compared with tyrosine kinase inhibitors alone in patients with epidermal growth factor receptor–mutated lung …
O Arrieta, F Barrón, MÁS Padilla, A Avilés-Salas… - JAMA …, 2019 - jamanetwork.com
Importance Metformin hydrochloride is emerging as a repurposed anticancer drug. Preclinical
and retrospective studies have shown that it improves outcomes across a wide variety of …
and retrospective studies have shown that it improves outcomes across a wide variety of …
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum …
Background Ramucirumab is a human IgG1 monoclonal antibody that targets the extracellular
domain of VEGFR-2. We aimed to assess efficacy and safety of treatment with docetaxel …
domain of VEGFR-2. We aimed to assess efficacy and safety of treatment with docetaxel …
[HTML][HTML] Nivolumab versus docetaxel in previously treated patients with advanced non–small-cell lung cancer: two-year outcomes from two randomized, open-label …
… Burgio, Martin Kohlhäeufl, David Waterhouse, Fabrice Barlesi, Scott Antonia, Oscar
Arrieta, Jérôme Fayette, Lucio Crinò, Naiyer Rizvi, Martin Reck, Matthew D. Hellmann …
Arrieta, Jérôme Fayette, Lucio Crinò, Naiyer Rizvi, Martin Reck, Matthew D. Hellmann …
[HTML][HTML] Five-year outcomes from the randomized, phase III trials checkmate 017 and 057: nivolumab versus docetaxel in previously treated non–small-cell lung …
…, A Pluzanski, O Arrieta… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
PURPOSE Immunotherapy has revolutionized the treatment of advanced non–small-cell lung
cancer (NSCLC). In two phase III trials (CheckMate 017 and CheckMate 057), nivolumab …
cancer (NSCLC). In two phase III trials (CheckMate 017 and CheckMate 057), nivolumab …
Triple‐negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity
…, E Bargalló, JL Aguilar, A Mohar, Ó Arrieta - Cancer, 2011 - Wiley Online Library
BACKGROUND: Triple‐negative breast cancer (TNBC) is defined as breast cancer that is
negative for estrogen receptor, progesterone receptor, and human epidermal growth factor …
negative for estrogen receptor, progesterone receptor, and human epidermal growth factor …
[HTML][HTML] Radiation-induced lung injury: current evidence
…, W Muñoz-Montaño, M Nuñez-Baez, O Arrieta - BMC pulmonary …, 2021 - Springer
Chemo-radiotherapy and systemic therapies have proven satisfactory outcomes as standard
treatments for various thoracic malignancies; however, adverse pulmonary effects, like …
treatments for various thoracic malignancies; however, adverse pulmonary effects, like …